Our identification of SPOP as a bona fide E3 ligase of the AR is highly relevant to prostate cancer, because SPOP-mediated degradation of AR protein is disrupted by its mutations identified in prostate cancer, as well as the majority of prostate cancer-derived AR splicing variants. Here, AR is linked to prostate carcinoma.